Bartlett & Co Wealth Management’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Bartlett & Co Wealth Management’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-100	Closed	-$86	–	917
2019 Q4	$86	Hold	100	–	–	﹤0.01%	854
2019 Q3	$56	Hold	100	–	–	﹤0.01%	865
2019 Q2	$52	Hold	100	–	–	﹤0.01%	761
2019 Q1	$45	Hold	100	–	–	﹤0.01%	732
2018 Q4	$48	Hold	100	–	–	﹤0.01%	690
2018 Q3	$0	Hold	100	–	–	﹤0.01%	750
2018 Q2	$50	Buy	+100	New	+$47	﹤0.01%	703

Bartlett & Co Wealth Management's GCVRZ Position: Q1 2020 in Review

Bartlett & Co Wealth Management sold out of Sanofi Contingent Value Rights (GCVRZ) in Q1 2020, closing a stake of 100 shares — an estimated $86 sold.

Bartlett & Co Wealth Management first reported a position in GCVRZ in Q2 2018 and held it in 7 quarters. The position peaked at $86 in Q4 2019. 2 funds tracked by Wall St. Rank hold GCVRZ as of Q1 2020.

Bartlett & Co Wealth Management reported no remaining Sanofi Contingent Value Rights position as of Q1 2020 after selling out during the quarter.
Bartlett & Co Wealth Management sold 100 Sanofi Contingent Value Rights shares in Q1 2020, an estimated $86.
Bartlett & Co Wealth Management first reported a position in Sanofi Contingent Value Rights in Q2 2018 and held it in 7 quarters.
Bartlett & Co Wealth Management's Sanofi Contingent Value Rights position peaked at $86 in Q4 2019.
2 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q1 2020.

Based on Bartlett & Co Wealth Management's 13F filing for Q1 2020, filed 13 Feb 2024.